- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/555 - Interferons [IFN]
Patent holdings for IPC class C07K 14/555
Total number of patents in this class: 301
10-year publication summary
|
23
|
22
|
22
|
27
|
19
|
22
|
26
|
28
|
13
|
9
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Opko Biologics Ltd. | 78 |
13 |
| The Regents of the University of California | 20745 |
10 |
| Superlab Far East Limited | 15 |
7 |
| Orionis Biosciences Inc. | 109 |
7 |
| Werewolf Therapeutics, Inc. | 65 |
7 |
| Toray Industries, Inc. | 7113 |
6 |
| Regeneron Pharmaceuticals, Inc. | 4701 |
6 |
| Evotec International GmbH | 88 |
5 |
| The Industry & Academic Cooperation in Chungnam National University (IAC) | 506 |
5 |
| Novagen Holding Corporation | 19 |
5 |
| Rutgers, The State University of New Jersey | 1973 |
5 |
| Sanofi | 4301 |
5 |
| CytomX Therapeutics, Inc. | 232 |
4 |
| Universiteit Gent | 1404 |
4 |
| Vib VZW | 905 |
4 |
| Orionis Biosciences BV | 80 |
4 |
| The Board of Trustees of the Leland Stanford Junior University | 6653 |
3 |
| Memed Diagnostics Ltd. | 80 |
3 |
| PharmaEssentia Corp. | 80 |
3 |
| Washington University | 1737 |
3 |
| Other owners | 192 |